Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemia.

Annals of hematology - 1 Jun 2014

Reuter Christoph W M, Krauter Jürgen, Onono Fredrick O, Bunke Tania, Damm Frederik, Thol Felicitas, Wagner Katharina, Göhring Gudrun, Schlegelberger Brigitte, Heuser Michael, Ganser Arnold, Morgan Michael A

Abstract excerpt

Transforming mutations in RAS genes are commonly found in human malignancies, including myeloid leukemias. To investigate the incidence, spectrum, and distribution of activating K- and N-RAS mutations in cytogenetically normal acute myeloid leukemia (CN-AML) patients, 204 CN-AML patients were scr...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow
Share to Disease-Free Survival
Share to DNA, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, ras

Share to Kaplan-Meier Estimate

Share to Leukemia, Myeloid, Acute

Share to Mutation, Missense

Share to Nucleophosmin

Source

Identifiers

PMID: 24737308
DOI: 10.1007/s00277-014-2061-9

Genes

NPM1
FLT3
IDH1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24737308-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemia.PMID 24737308Read ↗

High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patientsSemantic proximity Read ↗

Clinico-genomic characterization of RAS-mutant acute myeloid leukemia.Semantic proximity Read ↗

Clinical significance of RAS pathway alterations in pediatric acute myeloid leukemia.Semantic proximity Read ↗

RAS mutations in myeloid malignancies: revisiting old questions with novel insights and therapeutic perspectives.Semantic proximity Read ↗

N-ras mutation detection by pyrosequencing in adult patients with acute myeloid leukemia at a single institution.Semantic proximity Read ↗

NRAS mutations in de novo acute leukemia: prevalence and clinical significance.Semantic proximity Read ↗

RAS mutations in acute myeloid leukaemia patients: A review and meta-analysis.Semantic proximity Read ↗

RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years.Semantic proximity Read ↗

Isolated KRAS and NRAS mutations in adults with monocytosis and/or cytopenia(s).Semantic proximity Read ↗

NRASmutDNMT3Amut Clone Identifies a Subset of de novo Cytogenetically Normal Acute Myeloid Leukemia with Adverse Prognosis.Semantic proximity Read ↗

N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance.Semantic proximity Read ↗

Oncogenic NRAS, KRAS, and HRAS exhibit different leukemogenic potentials in mice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.